Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2023504 | Regulatory Peptides | 2007 | 5 Pages |
Neuropeptide W (NPW) is a novel hypothalamic peptide that activates the orphan G protein-coupled receptors, GPR7 and GPR8. Two endogenous molecular forms of NPW that consist of 23- and 30-amino acid residues were identified. Intracerebroventricular (i.c.v.) administration of NPW is known to suppress spontaneous-feeding at dark-phase and fasting-induced food intake and to decrease body weight and plasma growth hormone and to increase prolactin and corticosterone; however, little is known about its effect on other physiological functions.We examined the effects of i.c.v. administration of NPW30 (0.3 and 3 nmol) on the mean arterial pressure (MAP), heart rate (HR), and plasma norepinephrine and epinephrine in conscious rats. NPW30 (3 nmol) provoked increases in MAP (85.12 ± 3.16 to 106.26 ± 2.66 mm Hg) and HR (305.75 ± 13.76 to 428.45 ± 26.82 beats/min) and plasma norepinephrine (138.1 ± 18.1 to 297.2 ± 25.9 pg/ml) and epinephrine (194.6 ± 21.4 to 274.6 ± 22.7 pg/ml). Intravenously administered NPW30 (3 nmol) had no significant effects on MAP and HR. These results indicate that central NPW30 increases sympathetic nervous outflow and affects cardiovascular function.